Scarica l'app Stockscreener
0.599
0.18%
0.0011
Dopo l'orario di chiusura:
.59
-0.009
-1.50%
Precedente Chiudi:
$0.5979
Aprire:
$0.583
Volume 24 ore:
195.65K
Relative Volume:
0.18
Capitalizzazione di mercato:
$37.61M
Reddito:
$11.03M
Utile/perdita netta:
$-44.24M
Rapporto P/E:
-0.9661
EPS:
-0.62
Flusso di cassa netto:
$-42.61M
1 W Prestazione:
+3.65%
1M Prestazione:
-18.05%
6M Prestazione:
-40.69%
1 anno Prestazione:
-33.41%
Intervallo 1D:
$0.5815
$0.62
Intervallo di 1 settimana:
$0.5327
$0.669
Portata 52W:
$0.5327
$1.90
Hyperfine Inc Stock (HYPR) Company Profile
Nome
Hyperfine Inc
Settore
Industria
Telefono
866-796-6767
Indirizzo
351 NEW WHITFIELD STREET, GUILFORD
Confronta HYPR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HYPR
Hyperfine Inc
|
0.599 | 45.93M | 11.03M | -44.24M | -42.61M | -0.62 |
|
ABT
Abbott Laboratories
|
132.85 | 231.49B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.50 | 154.81B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
382.35 | 145.13B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
82.41 | 108.21B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.73 | 44.64B | 5.54B | 4.18B | 623.10M | 7.00 |
Hyperfine Inc Stock (HYPR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-08-11 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-05-31 | Iniziato | Evercore ISI | Outperform |
| 2022-04-14 | Iniziato | Wells Fargo | Overweight |
Hyperfine Inc Borsa (HYPR) Ultime notizie
Hyperfine Gets FDA Clearance For Optive AI Software, Marking Major Upgrade To Swoop MRI Imaging - Nasdaq
FDA OKs Hyperfine’s Optive AI Software for Swoop MR - Medical Product Outsourcing
Hyperfine Announces FDA Clearance Of Optive AI(TM) Software - marketscreener.com
Hyperfine announces FDA clearance of next-generation software - TipRanks
Hyperfine unveils advanced AI software for portable MRI By Investing.com - Investing.com Nigeria
Hyperfine unveils advanced AI software for portable MRI - Investing.com
Hyperfine Announces FDA Clearance of Optive AI™ Software, Introducing the Most Substantial Image Quality Improvement Ever for the Swoop® System - Business Wire
Hyperfine Chairperson R. Scott Huennekens Resigns - MSN
Hyperfine, Inc. (HYPR) Reports Q1 Loss, Lags Revenue Estimates - MSN
Hyperfine Holds Annual Stockholders Meeting - TipRanks
B. Riley Has Optimistic Outlook of Hyperfine Q3 Earnings - Defense World
B. Riley Cuts Hyperfine (NASDAQ:HYPR) Price Target to $1.00 - Defense World
Hyperfine Inc. Earnings Call: Transition and Growth - TipRanks
Hyperfine, Inc. to Participate in Upcoming Jefferies Global Healthcare Conference - 01net
Hyperfine (HYPR) Maintained as 'Buy' by B. Riley Securities, Price Target Lowered | HYPR Stock News - GuruFocus
Hyperfine price target lowered to $1 from $1.20 at B. Riley - TipRanks
B. Riley Reduces Price Target for Hyperfine (HYPR) After Sales M - GuruFocus
B. Riley Lowers Price Target on Hyperfine to $1 From $1.20, Keeps Buy Rating - marketscreener.com
Hyperfine (HYPR) Maintained as 'Buy' by B. Riley Securities, Pri - GuruFocus
Hyperfine Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) - Benzinga
Wells Fargo Updates Price Target and Rating for HYPR | HYPR Stoc - GuruFocus
Hyperfine (HYPR) Reports Lower Q1 Revenue, Optimistic About Futu - GuruFocus
Hyperfine, Inc. (NASDAQ:HYPR) Q1 2025 Earnings Call Transcript - Insider Monkey
Hyperfine’s net loss for Q1 2025 hits USD 9.4M - Medical Buyer
Hyperfine outlines 10%–20% revenue growth for 2025 as new product launches and office market entry drive diversification - MSN
Hyperfine Q1 2025 Earnings Call Transcript - MarketBeat
Hyperfine, Inc. Reports Q1 2025 Financial Results - TipRanks
Hyperfine reports Q1 EPS (12c), consensus (12c) - TipRanks
Earnings call transcript: Hyperfine Misses Q1 2025 Revenue Expectations By Investing.com - Investing.com Nigeria
Earnings call transcript: Hyperfine Misses Q1 2025 Revenue Expectations - Investing.com
Hyperfine Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Hyperfine Q1 2025 slides reveal portable MRI expansion strategy despite mixed results - Investing.com Australia
Hyperfine Q1 2025 slides reveal portable MRI expansion strategy despite mixed results By Investing.com - Investing.com South Africa
Hyperfine Inc (HYPR) Q1 2025 Earnings: EPS Meets Estimate at -$0 - GuruFocus
Hyperfine Inc Files For Offering Of Up To $50 Million Of Shares Of Class A Common Stock - marketscreener.com
Hyperfine, Inc. SEC 10-Q Report - TradingView
Hyperfine, Inc. Reports First Quarter 2025 Financial Results - The Manila Times
Hyperfine Inc (HYPR) Q1 2025 Earnings Report Preview: What To Lo - GuruFocus
Chipiron building ultra-low portable MRI scanner following $17M raise - BioWorld MedTech
Hyperfine (HYPR) Projected to Post Quarterly Earnings on Tuesday - Defense World
Renaissance Technologies LLC Boosts Stock Holdings in Hyperfine, Inc. (NASDAQ:HYPR) - Defense World
Hyperfine, Inc. to Announce First Quarter 2025 Financial Results on May 13, 2025 - Business Wire
Hyperfine Enrolls Initial Patients in NEURO PMR Study to Evaluate Use of AI-Powered Portable MRI in Neurology Offices - 01net
Hyperfine Enrolls First Patients in Portable MRI Evaluation Study - marketscreener.com
Hyperfine enrolls initial patients in NEURO PMR study - TipRanks
Revolutionary Portable MRI Secures Medicare Coverage as Major Clinical Trial Launches - Stock Titan
Hyperfine (NASDAQ:HYPR) Stock Price Up 0.5% – Should You Buy? - Defense World
HYPR Stock Price and Chart — NASDAQ:HYPR - TradingView
HYPR stock touches 52-week low at $0.76 amid market challenges - Investing.com
Lake Street Initiates Coverage of Hyperfine (HYPR) with Buy Recommendation - MSN
Lake Street starts Hyperfine stock with Buy, sets $1.50 target By Investing.com - Investing.com Australia
Hyperfine Inc Azioni (HYPR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Hyperfine Inc Azioni (HYPR) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| TEISSEYRE THOMAS | Chief Operating Officer |
Feb 18 '25 |
Sale |
1.20 |
3,237 |
3,884 |
84,990 |
| TEISSEYRE THOMAS | Chief Operating Officer |
Nov 18 '24 |
Sale |
0.85 |
2,800 |
2,380 |
88,227 |
| TEISSEYRE THOMAS | Chief Operating Officer |
Aug 16 '24 |
Sale |
1.05 |
2,746 |
2,883 |
91,027 |
0.09%
2.44%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):